Coral Products PLC reported continued operational progress but anticipates a dip in H2 FY26 profitability due to sales deferrals, attributed to customer contract timing and geopolitical factors, though these sales are considered postponed rather than lost. Meanwhile, ICFG Limited announced a delay in its FY25 audited results, prompting a temporary suspension of share trading from May 1, 2026. In a notable move for the veterinary sector, BlackRock, Inc. significantly increased its major holding in CVS Group plc to 6.63%, signaling growing institutional confidence.
Floor coverings distributor Coral Products CRU announced a trading update ahead of its financial year end, confirming continued operational progress in the second half of FY26. However, expected revenues from established customer contracts and new business wins have been deferred beyond FY26. This phasing was partly influenced by the ongoing Middle East conflict, leading to reduced second-half profitability, though the company stresses sales are deferred, not lost.
ICFG ICFG, an international financial services group, announced a delay in publishing its audited financial results for the year ended 31 December 2025. The company stated that additional time is required to finalise certain procedures with its auditor, Ernst & Young. As a direct result of this delay, trading in ICFG's shares is expected to be temporarily suspended from May 1, 2026, until the audited financial statements are made public, raising investor concerns.
A major institutional investor, BlackRock, Inc., has significantly increased its holding in veterinary services group CVS Group CVSG. The notification revealed that BlackRock now holds a total of 6.63% of voting rights, combining direct shares and financial instruments, up from a previously reported 5.26%. This substantial increase in ownership by a leading asset manager often signals growing institutional confidence in the company's prospects and valuation.